Skip to main content
Future Journal of Pharmaceutical Sciences

Table 3 Mean ± SD of BA pharmacokinetics parameters for BA-suspension and BA-SLNs

From: Characterization, cellular uptake in Caco-2 cells and physiologically based pharmacokinetic modeling of baicalin-loaded solid lipid nanoparticles

Parameters

Treatments

BA-suspension

BA-SLNs

Tmax (h)*

1.98 (1.2–2.5)

1.58 (1.1–2.3)

Cmax(ng/mL)

288.82 ± 98.90

421.46 ± 136.50

AUC0–24 h (ng/mL h)

596.77 ± 102.20

1311.09 ± 660.0

  1. *Median (range)
Back to article page